A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.
Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, et al. J Clin Psychiatry. 2009 Dec; 70(12):1636-44. Epub 2009 Aug 25.